Showing results (1-10 of 200) with videos related to
Sort By:
Pageof 20
International Journal of Clinical Practice|June 21, 2005
Type 2 diabetes mellitus: a cardiovascular perspectiveG I Varughese, J Tomson, G Y H LipJournal of Internal Medicine|March 30, 2007
Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes TrialG I Varughese, J V Patel, J Tomson, et al.Journal of Thrombosis and Haemostasis : JTH|July 26, 2011
Stroke in atrial fibrillation: epidemiology and thromboprophylaxisG Y H LipJournal of Thrombosis and Haemostasis : JTH|March 5, 2013
Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentaryG Y H LipThe Journal of the Royal College of Physicians of Edinburgh|April 21, 2012
What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?G Y H LipInternational Journal of Clinical Practice|January 18, 2006
Antithrombotic therapy for congestive heart failureI Chung, G Y H LipQJM : Monthly Journal of the Association of Physicians|September 12, 2007
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic reviewM Hughes, G Y H Lip, Heart (British Cardiac Society)|March 18, 2005
How good is anticoagulation control in non-valvar atrial fibrillation? Observations on the elderly, ethnicity, patient perceptions, and understanding of AF thromboprophylaxisA Choudhury, G Y H LipHamostaseologie|January 20, 2009
Thrombosis prophylaxis in patients with ischaemic (cardioembolic) stroke. How long is long enough?G Y H Lip, S KrishnamoorthyHamostaseologie|October 7, 2008
The endothelium and atrial fibrillation. The prothrombotic state revisitedB Freestone, G Y H LipPageof 20